SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-729880
Filing Date
2016-10-04
Accepted
2016-10-04 07:04:55
Documents
4
Period of Report
2016-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d237236d8k.htm 8-K 26292
2 EX-99.1 d237236dex991.htm EX-99.1 26077
3 GRAPHIC g237236image01.jpg GRAPHIC 7501
4 GRAPHIC g237236image02.jpg GRAPHIC 8026
  Complete submission text file 0001193125-16-729880.txt   75461
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 161917164
SIC: 2834 Pharmaceutical Preparations